CVS’ Q3 sales and earnings top projections
WOONSOCKET, R.I. — CVS Health beat Wall Street’s projections for third quarter sales and earnings, and again lifted its full-year guidance as store traffic rose for prescriptions and COVID-19 shots. Adjusted earnings per share for the three months ended September 30 jumped 18.7% from a year earlier to $1.97, topping the average analyst prediction of
